Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMDP) Restructuring Costs (2021 - 2025)

Historic Restructuring Costs for LifeMD (LFMDP) over the last 4 years, with Q3 2025 value amounting to $6.7 million.

  • LifeMD's Restructuring Costs fell 745.24% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.8 million, marking a year-over-year increase of 8022.06%. This contributed to the annual value of $35.8 million for FY2024, which is 4553.29% up from last year.
  • Per LifeMD's latest filing, its Restructuring Costs stood at $6.7 million for Q3 2025, which was down 745.24% from $10.9 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Restructuring Costs peaked at $15.8 million during Q4 2024, and registered a low of $20896.0 during Q2 2021.
  • Its 4-year average for Restructuring Costs is $7.2 million, with a median of $7.7 million in 2024.
  • Data for LifeMD's Restructuring Costs shows a peak YoY increase of 3200.25% (in 2025) and a maximum YoY decrease of 745.24% (in 2025) over the last 5 years.
  • Over the past 4 years, LifeMD's Restructuring Costs (Quarter) stood at $20896.0 in 2021, then surged by 118.51% to $45659.0 in 2022, then surged by 34487.86% to $15.8 million in 2024, then crashed by 57.56% to $6.7 million in 2025.
  • Its Restructuring Costs was $6.7 million in Q3 2025, compared to $10.9 million in Q2 2025 and $8.5 million in Q1 2025.